The lung in the immunocompromised patient. Infectious complications part 2.
Pulmonary infections decisively contribute to morbidity and mortality in immunocompromised patients. Bacterial, mycobacterial and infections with Pneumocystis carinii have been reviewed in an article in the last issue of Respiration. In this review, viral and fungal pulmonary infections are discussed in HIV-positive patients and in patients treated with high-dose chemotherapy, stem cell or solid-organ transplantation.
Tamm
M
M
Division of Pneumology, University Hospital Basel, Switzerland. michaelt@mailmed.usyd.edu.au
D064420:Drug-Related Side Effects and Adverse Reactions; D006679:HIV Seropositivity / Q000150:complications; D006801:Humans; D016867:Immunocompromised Host / Q000502:physiology*; D008171:Lung Diseases / Q000209:etiology*; D009181:Mycoses / Q000209:etiology*; D016377:Organ Transplantation; D011183:Postoperative Complications; D033581:Stem Cell Transplantation; D014777:Virus Diseases / Q000209:etiology*